---
layout: post
title: "中药板块景气度扩散 医药股掀起涨停潮 明年医药能否虎虎生威？"
date: 2021-12-27 17:37:43 +0800
categories: emnews
tags: 东财滚动新闻
---
> 今日(12月27日)，医药股大幅走强，医药商业板块领涨两市，截至收盘，柳药股份、大参林涨停。老百姓、益丰药房涨幅逾8%，NMN概念、中药、医药电商、仿制药一致性、化学制药等子板块涨幅均逾3%，其中，中药概念继续强势，方盛制药、特一药业、精华制药、龙津药业、佛慈制药、大理药业涨停，红阳药业涨逾18%，陇神戎发涨逾12%。

<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/90.BK1040" data-code="BK1040|90|1" data-code2="BK1040|90|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=90.BK1040&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BK1040_0" data-code="K BK1040|90|1" data-code2="K BK1040|90|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>今日(12月27日)，医药股大幅走强，<span id="bk_90.BK1042"><a href="http://quote.eastmoney.com/unify/r/90.BK1042" class="keytip" data-code="90,BK1042">医药商业</a></span><span id="bkquote_90.BK1042"></span>板块领涨两市，截至收盘，<span id="stock_1.603368"><a href="http://quote.eastmoney.com/unify/r/1.603368" class="keytip" data-code="1,603368">柳药股份</a></span><span id="quote_1.603368"></span>、<span id="stock_1.603233"><a href="http://quote.eastmoney.com/unify/r/1.603233" class="keytip" data-code="1,603233">大参林</a></span><span id="quote_1.603233"></span>涨停。<span id="stock_1.603883"><a href="http://quote.eastmoney.com/unify/r/1.603883" class="keytip" data-code="1,603883">老百姓</a></span><span id="quote_1.603883"></span>、<span id="stock_1.603939"><a href="http://quote.eastmoney.com/unify/r/1.603939" class="keytip" data-code="1,603939">益丰药房</a></span><span id="quote_1.603939"></span>涨幅逾8%，NMN概念、<span id="bk_90.BK1040"><a href="http://quote.eastmoney.com/unify/r/90.BK1040" class="keytip" data-code="90,BK1040">中药</a></span><span id="bkquote_90.BK1040"></span>、医药电商、仿制药一致性、<span id="bk_90.BK0465"><a href="http://quote.eastmoney.com/unify/r/90.BK0465" class="keytip" data-code="90,BK0465">化学制药</a></span><span id="bkquote_90.BK0465"></span>等子板块涨幅均逾3%，其中，<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1040" class="em_stock_key_common" data-code="90,BK1040">中药</span>概念继续强势，<span id="stock_1.603998"><a href="http://quote.eastmoney.com/unify/r/1.603998" class="keytip" data-code="1,603998">方盛制药</a></span><span id="quote_1.603998"></span>、<span id="stock_0.002728"><a href="http://quote.eastmoney.com/unify/r/0.002728" class="keytip" data-code="0,002728">特一药业</a></span><span id="quote_0.002728"></span>、<span id="stock_0.002349"><a href="http://quote.eastmoney.com/unify/r/0.002349" class="keytip" data-code="0,002349">精华制药</a></span><span id="quote_0.002349"></span>、<span id="stock_0.002750"><a href="http://quote.eastmoney.com/unify/r/0.002750" class="keytip" data-code="0,002750">龙津药业</a></span><span id="quote_0.002750"></span>、<span id="stock_0.002644"><a href="http://quote.eastmoney.com/unify/r/0.002644" class="keytip" data-code="0,002644">佛慈制药</a></span><span id="quote_0.002644"></span>、<span id="stock_1.603963"><a href="http://quote.eastmoney.com/unify/r/1.603963" class="keytip" data-code="1,603963">大理药业</a></span><span id="quote_1.603963"></span>涨停，红阳药业涨逾18%，<span id="stock_0.300534"><a href="http://quote.eastmoney.com/unify/r/0.300534" class="keytip" data-code="0,300534">陇神戎发</a></span><span id="quote_0.300534"></span>涨逾12%。</p><center><img src="https://dfscdn.dfcfw.com/download/D24920315208677619031.jpg" alt="image" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><strong><span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1040" class="em_stock_key_common" data-code="90,BK1040">中药</span>板块景气度扩散，市场聚焦低估值医药股</strong></p><p>12月下旬以来，中药板块持续走强，截止今日(12月27日)收盘，板块指数近六日涨幅近16%，个股方面，以近六日涨跌幅来统计，<span web="1" href="http://quote.eastmoney.com/unify/r/0.300534" class="em_stock_key_common" data-code="0,300534">陇神戎发</span>涨幅近115%，<span web="1" href="http://quote.eastmoney.com/unify/r/0.002750" class="em_stock_key_common" data-code="0,002750">龙津药业</span>涨近51%，<span id="stock_0.300026"><a href="http://quote.eastmoney.com/unify/r/0.300026" class="keytip" data-code="0,300026">红日药业</a></span><span id="quote_0.300026"></span>涨近47%，<span id="stock_0.002873"><a href="http://quote.eastmoney.com/unify/r/0.002873" class="keytip" data-code="0,002873">新天药业</a></span><span id="quote_0.002873"></span>、<span id="stock_1.600129"><a href="http://quote.eastmoney.com/unify/r/1.600129" class="keytip" data-code="1,600129">太极集团</a></span><span id="quote_1.600129"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002349" class="em_stock_key_common" data-code="0,002349">精华制药</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002644" class="em_stock_key_common" data-code="0,002644">佛慈制药</span>涨幅逾30%。</p><center><img src="https://dfscdn.dfcfw.com/download/D24918956045129229550.jpg" alt="image" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p style="text-align:center;">注：中药股近六日涨跌幅(截止12月27日收盘)</p><p>中药板块的上涨主要源自对于估值修复行情的预期，<span id="stock_1.600918"><a href="http://quote.eastmoney.com/unify/r/1.600918" class="keytip" data-code="1,600918">中泰证券</a></span><span id="quote_1.600918"></span>指出，政策持续积极鼓励中医药发展，年初国务院发布《关于加快中医药特色发展的若干政策措施》明确了国家多层次、多方位鼓励中医药发展的决心，今年以来中药新药获批上市加速也印证了政策扶持力度之大。中药企业当前普遍处于历史估值低位，多数公司估值对应22年仅10-20倍PE左右，配置价值凸显。</p><p>受中药估值修复行情带动，<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1042" class="em_stock_key_common" data-code="90,BK1042">医药商业</span>等低估值医药板块也迎来上涨。<span web="1" href="http://quote.eastmoney.com/unify/r/1.600918" class="em_stock_key_common" data-code="1,600918">中泰证券</span>认为，在20年的高基数影响下，21年药店板块<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>承压，疫情反复亦影响了部分门店经营，行业估值回到历史偏低水平。主要上市药房21年前三季度新开门店数均已超20年全年，新店经过一年左右培育期，有望自22年起贡献利润。基数效应减弱叠加新店利润释放，龙头连锁药店业绩拐点向上趋势明确，有望迎来估值修复。</p><p><strong>明年板块机会可能较散，关注优质<span id="Info.3123"><a href="http://fund.eastmoney.com/GP_jzzzl.html" class="infokey">股基</a></span>本面变化</strong></p><p>回顾今年医药板块，整体呈现先扬后抑的走势，直至11月开始，板块指数再度开启修复。国盛<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>指出，大热板块的抽水效应、医药政策预期的混沌引发过分担忧、市场环境加剧悲观情绪，“内忧外患”下全年医药板块呈现波动发展。究其本质，今年医药是对前期过高估值的消化。展望未来，人口结构跳跃式进入老龄化，老龄化将带来刚需医药扩容、健康消费升级加剧消费医药渗透率提升，医药行业长期比较优势明显。</p><center><img src="https://dfscdn.dfcfw.com/download/D24635628710546952146.jpg" alt="image" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p>投资策略上，<span id="stock_0.002926"><a href="http://quote.eastmoney.com/unify/r/0.002926" class="keytip" data-code="0,002926">华西证券</a></span><span id="quote_0.002926"></span>指出，过去2~3年，“选对赛道、选行业龙头”的投资策略取得了持续的超额收益，但随着过去几年上涨累积下来的涨幅，上述策略下选出来的黄金赛道的个股，当前也处于估值相对高位，虽然从行业发展趋势看，仍然中长期看好，但从二级市场投资角度看，“买赛道、买龙头”的投资策略，轻易获得超额收益的难度将会加大。</p><p>展望明年，<span web="1" href="http://quote.eastmoney.com/unify/r/0.002926" class="em_stock_key_common" data-code="0,002926">华西证券</span>认为，<strong>明年医药板块的投资机会会比较“散”，更多投资机会来自“自下而上”个股的选择，挖掘“基本面具有积极显著向好变化、估值较低”的个股，更加容易获得投资机会。</strong>赛道选择上，顺应医药行业发展趋势和政策走势，中长期看好<strong>CXO、<span id="bk_90.BK0727"><a href="http://quote.eastmoney.com/unify/r/90.BK0727" class="keytip" data-code="90,BK0727">医疗服务</a></span><span id="bkquote_90.BK0727"></span>、可选医疗消费板块(医美、 疫苗、生长激素、中药消费品)、创新药板块、<span id="bk_90.BK1041"><a href="http://quote.eastmoney.com/unify/r/90.BK1041" class="keytip" data-code="90,BK1041">医疗器械</a></span><span id="bkquote_90.BK1041"></span>板块具有创新能力的优质公司</strong>。具体受益的细分领域及标的：</p><p>CXO领域：<strong><span id="stock_0.300363"><a href="http://quote.eastmoney.com/unify/r/0.300363" class="keytip" data-code="0,300363">博腾股份</a></span><span id="quote_0.300363"></span>、<span id="stock_1.688202"><a href="http://quote.eastmoney.com/unify/r/1.688202" class="keytip" data-code="1,688202">美迪西</a></span><span id="quote_1.688202"></span>、<span id="stock_1.603259"><a href="http://quote.eastmoney.com/unify/r/1.603259" class="keytip" data-code="1,603259">药明康德</a></span><span id="quote_1.603259"></span>、<span id="stock_1.603456"><a href="http://quote.eastmoney.com/unify/r/1.603456" class="keytip" data-code="1,603456">九洲药业</a></span><span id="quote_1.603456"></span>、<span id="stock_1.603127"><a href="http://quote.eastmoney.com/unify/r/1.603127" class="keytip" data-code="1,603127">昭衍新药</a></span><span id="quote_1.603127"></span>、<span id="stock_0.002821"><a href="http://quote.eastmoney.com/unify/r/0.002821" class="keytip" data-code="0,002821">凯莱英</a></span><span id="quote_0.002821"></span>、<span id="stock_0.300759"><a href="http://quote.eastmoney.com/unify/r/0.300759" class="keytip" data-code="0,300759">康龙化成</a></span><span id="quote_0.300759"></span>、<span id="stock_1.688076"><a href="http://quote.eastmoney.com/unify/r/1.688076" class="keytip" data-code="1,688076">诺泰生物</a></span><span id="quote_1.688076"></span>、<span id="Info.116.01873"><a href="http://quote.eastmoney.com/unify/r/116.01873" class="keytip" data-code="116,01873">维亚生物</a></span></strong>；医美领域：<strong><span id="stock_0.300896"><a href="http://quote.eastmoney.com/unify/r/0.300896" class="keytip" data-code="0,300896">爱美客</a></span><span id="quote_0.300896"></span>、<span id="stock_0.000963"><a href="http://quote.eastmoney.com/unify/r/0.000963" class="keytip" data-code="0,000963">华东医药</a></span><span id="quote_0.000963"></span></strong>；疫苗：<strong><span id="stock_0.300122"><a href="http://quote.eastmoney.com/unify/r/0.300122" class="keytip" data-code="0,300122">智飞生物</a></span><span id="quote_0.300122"></span>、<span id="stock_1.688276"><a href="http://quote.eastmoney.com/unify/r/1.688276" class="keytip" data-code="1,688276">百克生物</a></span><span id="quote_1.688276"></span>、<span id="stock_0.300601"><a href="http://quote.eastmoney.com/unify/r/0.300601" class="keytip" data-code="0,300601">康泰生物</a></span><span id="quote_0.300601"></span></strong>； 生长激素：<strong><span id="stock_0.000661"><a href="http://quote.eastmoney.com/unify/r/0.000661" class="keytip" data-code="0,000661">长春高新</a></span><span id="quote_0.000661"></span></strong>；创新药及制剂出口领域：<strong><span id="stock_1.600276"><a href="http://quote.eastmoney.com/unify/r/1.600276" class="keytip" data-code="1,600276">恒瑞医药</a></span><span id="quote_1.600276"></span>、<span id="Info.116.02096"><a href="http://quote.eastmoney.com/unify/r/116.02096" class="keytip" data-code="116,02096">先声药业</a></span>、<span id="stock_0.002653"><a href="http://quote.eastmoney.com/unify/r/0.002653" class="keytip" data-code="0,002653">海思科</a></span><span id="quote_0.002653"></span></strong>；<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK1041" class="em_stock_key_common" data-code="90,BK1041">医疗器械</span>领域：<strong><span id="stock_1.603309"><a href="http://quote.eastmoney.com/unify/r/1.603309" class="keytip" data-code="1,603309">维力医疗</a></span><span id="quote_1.603309"></span>、<span id="stock_1.603987"><a href="http://quote.eastmoney.com/unify/r/1.603987" class="keytip" data-code="1,603987">康德莱</a></span><span id="quote_1.603987"></span></strong>。</p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_Vote_Start --><center style="text-align:left;"><div class="em_vote" vote_id="14962" vote_title="%u3010%u80A1%u6C11%u8C03%u67E5%u95EE%u5377%u30112021%uFF0C%u4F60%u8D5A%u94B1%u4E86%u5417%uFF1F" style="display:none;"> </div> </center><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1353,202112272227369663.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)